Key facts
- ReqMed’s last known valuation is $57.6M (Apr 2026).
- It has raised $9.0M; the latest was IPO ($9.4M) in Apr 2026.
- Notable investors include CEJ Capital, Cyberdyne (Therapeutic Devices), Edge Labs, MCC LLC, Oji Holdings — 9 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 9 names
- ·Watchlist + deal alerts for ReqMed
- ·The full record, as it builds
Funding rounds
No funding rounds for ReqMed are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About ReqMed
ReqMed Co Ltd focuses on developing treatments for unmet medical needs. It conducts clinical development activities, obtains regulatory approvals for manufacturing and sales, and commercializes its pharmaceutical products to patients.
- Sector
- Healthcare
- HQ
- Tokyo, Japan
- Founded
- 1998
- Employees
- 22
- Website
- reqmed.co.jp/
- Ownership
- Privately Held (backing)
ReqMed doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in ReqMed shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on ReqMed in its N-PORT filings yet. We sweep new filings monthly.